In another study, BMS-204352 efficiently reversed the cortical hyperexcitability and increased acoustic startle seen in FMR1 knockout mice (Carreno-Munoz et al., 2018), suggesting that this treatment could alleviate sensory hypersensitivity symptoms in FXS patients. The gene discussed is FMR1; the disease is fragile X syndrome.